The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Bisgaier Charles Phd since 2007.
The trader's CIK number is 1381030.
At the time of the last reporting, Bisgaier Charles Phd was the President of Gemphire Therapeutics Inc.. (stock ticker symbol GEMP).
Also see all insider trading activities at Gemphire Therapeutics Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2017 | GEMP | 0 | $0 | 0 | $0 | 4,474 | $6,013 |
| 2016 | GEMP | 51,750 | $517,500 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2007 | PP | 10,000 | $46,400 | 0 | $0 | 0 | $0 |
1. Gemphire Therapeutics Inc. (GEMP)
2. Synthetic Biologics, Inc. (PP)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-07-31 | GEMP | Option Ex | 4,474 | 1.34 | 6,013 |
| 2016-08-10 | GEMP | Buy | 51,750 | 10.00 | 517,500 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2007-07-16 | PP | Buy | 10,000 | 4.64 | 46,400 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bisgaier Charles Phd (President of Gemphire Therapeutics Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.